CBL & Associates Properties slipped to 4.6x AFFO with a 2026 forecast and debt reduction. GDP and occupancy are risks. Check ...
NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results